- Home
- JAZZ vs TTD Comparison
JAZZ vs TTD Comparison
Compare JAZZ & TTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JAZZ | TTD |
|---|---|---|
| Founded | 2003 | 2009 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.0B | 13.0B |
| IPO Year | 2007 | 2016 |
Fundamental Metrics
Financial Performance| Metric | JAZZ | TTD |
|---|---|---|
| Price | $236.27 | $18.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 34 |
| Target Price | ★ $217.57 | $46.22 |
| AVG Volume (30 Days) | 810.7K | ★ 16.6M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.38 |
| EPS | ★ 4.43 | 0.08 |
| Revenue | $1,618,693,000.00 | ★ $2,896,284,000.00 |
| Revenue This Year | $6.22 | $13.94 |
| Revenue Next Year | $7.68 | $12.61 |
| P/E Ratio | ★ $53.20 | $236.38 |
| Revenue Growth | N/A | ★ 18.47 |
| 52 Week Low | $105.00 | $18.37 |
| 52 Week High | $243.32 | $91.45 |
Technical Indicators
Market Signals| Indicator | JAZZ | TTD |
|---|---|---|
| Relative Strength Index (RSI) | 58.56 | 37.43 |
| Support Level | $224.23 | N/A |
| Resistance Level | $243.32 | $24.25 |
| Average True Range (ATR) | 6.98 | 1.21 |
| MACD | -1.65 | -0.22 |
| Stochastic Oscillator | 60.69 | 11.54 |
Price Performance
Historical ComparisonAbout JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About TTD The Trade Desk Inc.
The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on devices like computers, smartphones, and connected TVs. It uses data in an iterative manner to optimize the performance of ad impressions purchased. The firm's platform is referred to as a demand-side platform in the digital ad industry, and it generates revenue from fees based on a percentage of what its clients spend on advertising.